Regentis Biomaterials Ltd. received a Schedule 13G from Rosalind Advisors Inc., Rosalind Master Fund L.P., Steven Salamon and Gilad Aharon regarding their beneficial ownership of its common shares.
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Regentis Biomaterials Ltd. received a Schedule 13G from Rosalind Advisors Inc., Rosalind Master Fund L.P., Steven Salamon and Gilad Aharon regarding their beneficial ownership of its common shares. The group reports up to 1,428,570 securities tied to Regentis, consisting of 701,685 common shares and 726,885 shares issuable upon exercise of warrants. The reported positions are calculated against 7,023,921 ordinary shares outstanding as of July 8, 2026. The filing notes “blocker” provisions, so the actual number of shares beneficially owned is lower than the full convertible and exercisable amount. Rosalind Advisors and Mr. Salamon may be deemed beneficial owners through their advisory roles but explicitly disclaim beneficial ownership of the shares.
Key Figures
Common shares held:701,685 sharesWarrant shares issuable:726,885 sharesTotal securities referenced:1,428,570+1 more
4 metrics
Common shares held701,685 sharesRegentis common shares reported as beneficially owned by the Rosalind group
Warrant shares issuable726,885 sharesRegentis common shares issuable upon exercise of warrants held by the reporting persons
Total securities referenced1,428,570Sum of common shares and shares issuable upon warrant exercise tied to Regentis
Shares outstanding7,023,921 sharesRegentis ordinary shares outstanding as of July 8, 2026, used for ownership calculations
"The percentage is calculated based upon 7,023,921 ordinary shares of the Issuers common stock"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
beneficial ownerregulatory
"may be deemed to be the beneficial owner of shares held by RMF"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
shared voting powerfinancial
"Shared Voting Power 1,428,570.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive powerfinancial
"Shared Dispositive Power 1,428,570.00"
blockersfinancial
"do not give effect to such blockers. Therefore, the actual number of shares"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership in RGNT does Rosalind Advisors report on this Schedule 13G?
Rosalind-related filers report up to 1,428,570 Regentis Biomaterials securities, including 701,685 common shares and 726,885 shares issuable upon warrants. Blocker provisions mean actual beneficial ownership is lower than this fully converted amount.
How many Regentis (RGNT) shares are outstanding for this Schedule 13G calculation?
The ownership percentages are based on 7,023,921 Regentis ordinary shares outstanding as of July 8, 2026, as referenced from an F-1 filing. This outstanding share count serves as the denominator for the beneficial ownership calculation.
Which entities and individuals are reporting beneficial ownership of RGNT?
The Schedule 13G lists Rosalind Advisors Inc., Rosalind Master Fund L.P., Steven Salamon, and Gilad Aharon. Rosalind Advisors is investment advisor to the fund; Salamon and Aharon serve as portfolio managers associated with the advisor and the fund.
What voting and dispositive power over RGNT shares do the reporting persons have?
Each reporting person has 0 sole voting or dispositive power and shared voting and dispositive power over 701,685 Regentis common shares. This reflects coordinated control through the fund and advisory relationships rather than individual direct holdings.
Do Rosalind Advisors and Steven Salamon claim full beneficial ownership of RGNT shares?
No. While Rosalind Advisors and Steven Salamon may be deemed beneficial owners because they advise the fund, they expressly disclaim beneficial ownership of the Regentis shares reported as held by Rosalind Master Fund L.P.
How are RGNT warrants included in the reported Rosalind ownership?
The filing states that 726,885 Regentis common shares are issuable upon exercise of warrants. These, together with 701,685 common shares, form the reported 1,428,570 securities, though blocker provisions limit exercisability and effective ownership.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
REGENTIS BIOMATERIALS LTD.
(Name of Issuer)
Common Shares
(Title of Class of Securities)
001219096
(CUSIP Number)
06/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
001219096
1
Names of Reporting Persons
Rosalind Advisors, Inc.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
ONTARIO, CANADA
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,428,570.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,428,570.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,428,570.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.9 %
12
Type of Reporting Person (See Instructions)
CO
Comment for Type of Reporting Person: This percentage is calculated based upon 7,023,921 ordinary shares of the Issuers common stock outstanding as of July 8, 2026, based on the F1 Filing on July 8, 2026. However, as more fully described in Item 4, the securities reported in rows 6, 8 and 9 show the number of shares of Common Stock that would be issuable upon full conversion and exercise of such reported securities and do not give effect to such blockers. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows 6, 8 and 9.
(6) 701,685 shares of Common Stock
726,885 shares of Common Stock issuable upon exercise of warrants
SCHEDULE 13G
CUSIP Number(s):
001219096
1
Names of Reporting Persons
SALAMON STEVEN A J
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
ONTARIO, CANADA
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,428,570.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,428,570.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,428,570.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.9 %
12
Type of Reporting Person (See Instructions)
IN
Comment for Type of Reporting Person: (6) 701,685 shares of Common Stock
726,885 shares of Common Stock issuable upon exercise of warrants
SCHEDULE 13G
CUSIP Number(s):
001219096
1
Names of Reporting Persons
Aharon Gil
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
ONTARIO, CANADA
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,428,570.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,428,570.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,428,570.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.9 %
12
Type of Reporting Person (See Instructions)
IN
Comment for Type of Reporting Person: (6) 701,685 shares of Common Stock
726,885 shares of Common Stock issuable upon exercise of warrants
SCHEDULE 13G
CUSIP Number(s):
001219096
1
Names of Reporting Persons
Rosalind Master Fund L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,428,570.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,428,570.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,428,570.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.9 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: (6) 701,685 shares of Common Stock
726,885 shares of Common Stock issuable upon exercise of warrants
Rosalind Advisors Inc. Advisor to RMF
Rosalind Master Fund L.P. RMF
Steven Salamon President
Steven Salamon is the portfolio manager of the Advisor which advises RMF.
Gilad Aharon is the portfolio manager and member of the Advisor which advises RMF.
(b)
Address or principal business office or, if none, residence:
Rosalind Advisors, Inc.
15 Wellesley Street West
Suite 326
Toronto, Ontario
M4Y 0G7 Canada
Rosalind Master Fund L.P.
P.O. Box 309
Ugland House, Grand Cayman
KY1-1104, Cayman Islands
Steven Salamon
15 Wellesley Street West
Suite 326
Toronto, Ontario
M4Y 0G7 Canada
Gilad Aharon
15 Wellesley Street West
Suite 326
Toronto, Ontario
M4Y 0G7 Canada
(c)
Citizenship:
Mr. Salamon and Mr. Aharon are citizens of Canada, resident in Ontario
(d)
Title of class of securities:
Common Shares
(e)
CUSIP Number(s):
001219096
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
The information as of the date of the event which requires filing of this statement required by Items 4a to c is set forth in Rows 7 to 13 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. The percentage set forth in Row 11 of the cover page for each Reporting Person is based upon 7,023,921 ordinary shares of the Issuers common stock outstanding as of July 8, 2026, based on the F1 Filing on July 8, 2026.
Rosalind Advisors Inc. is the investment advisor to RMF and may be deemed to be the beneficial owner of shares held by RMF. Steven Salamon is the portfolio manager of the Advisor and may be deemed to be the beneficial owner of shares held by RMF. Notwithstanding the foregoing, the Advisor and Mr. Salamon disclaim beneficial ownership of the shares.
(b)
Percent of class:
Rosalind Advisors Inc. 9.99%
Rosalind Master Fund L.P. 9.99%
Steven Salamon 9.99%
Gilad Aharon 9.99%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
Rosalind Advisors Inc. 701,685
Rosalind Master Fund L.P. 701,685
Steven Salamon 701,685
Gilad Aharon 701,685
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
Rosalind Advisors Inc. 701,685
Rosalind Master Fund L.P. 701,685
Steven Salamon 701,685
Gilad Aharon 701,685
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Rosalind Advisors, Inc.
Signature:
Steven Salamon
Name/Title:
President
Date:
08/13/2026
SALAMON STEVEN A J
Signature:
Steven Salamon
Name/Title:
Steven Salamon
Date:
08/13/2026
Aharon Gil
Signature:
Gil Aharon
Name/Title:
Gil Aharon
Date:
08/13/2026
Rosalind Master Fund L.P.
Signature:
Mike McDonald
Name/Title:
Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
